Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
New Open Innovation platform launched offering access to Compound Bank and partnering programmes
-
Forxiga® receives regulatory approval in Japan for the treatment of type 2 diabetes
-
AstraZeneca proposes appointment of Ann Cairns as Non-Executive Director
-
AstraZeneca announces sale of Alderley Park site in Cheshire, UK
-
AstraZeneca and Korea Health Industry Development Institute to establish oncology research programme
-
US FDA approves Bydureon® Pen (exenatide extended-release for injectable suspension) for once-weekly treatment of adults with type 2 diabetes
-
US FDA approves orphan drug MYALEPT™ (metreleptin for injection)
-
AstraZeneca scientists to work alongside researchers at Cancer Research UK Cambridge Institute
-
AstraZeneca PLC fourth quarter and full year results 2013
-
AstraZeneca completes the acquisition of Bristol-Myers Squibb share of global diabetes alliance
Latest articles and press releases
All of our latest press releases and articles are available to explore
